Teo Uysal

Company: ERX Pharmaceuticals

Job title: Chief Executive Officer

Seminars:

First-in-Class Leptin Sensitizer ERX1000, a Novel Treatment Paradigm for Obesity 11:00 am

Understanding that leptin, a hormone that regulates appetite and energy expenditure, is a major obstacle in achieving and maintaining weight loss Unveiling a new and differentiated mechanism of action for the treatment of obesity How is a leptin sensitizer different from and complimentary to GLP1 therapies?Read more

day: Day Two